|
LY6G5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.171510E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.093900E-02 |
| Normal-vs-Stage2 |
4.118100E-03 |
| Normal-vs-Stage3 |
5.717700E-03 |
| Normal-vs-Stage4 |
3.261800E-01 |
| Stage1-vs-Stage2 |
2.268200E-01 |
| Stage1-vs-Stage3 |
3.444800E-01 |
| Stage1-vs-Stage4 |
5.881200E-01 |
| Stage2-vs-Stage3 |
6.404800E-01 |
| Stage2-vs-Stage4 |
2.069600E-01 |
| Stage3-vs-Stage4 |
3.153000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.916400E-02 |
| Normal-vs-AfricanAmerican |
7.289600E-02 |
| Normal-vs-Asian |
6.440600E-01 |
| Caucasian-vs-AfricanAmerican |
7.944000E-01 |
| Caucasian-vs-Asian |
1.045680E-02 |
| AfricanAmerican-vs-Asian |
3.762300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.305200E-01 |
| Normal-vs-Female |
2.801800E-03 |
| Male-vs-Female |
5.543700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.808220E-02 |
| Normal-vs-Age(41-60Yrs) |
2.566100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.334200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.011600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.677800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.001800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.986600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.696200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.265800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.810800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.90809999997843E-06 |
| Classical-VS-Follicular |
3.222300E-03 |
| Classical-VS-Other |
6.153400E-01 |
| Classical-VS-Normal |
1.428830E-01 |
| Tall-VS-Follicular |
1.998780E-01 |
| Tall-VS-Other |
1.571550E-01 |
| Tall-VS-Normal |
2.95390000004669E-06 |
| Follicular-VS-Other |
6.110600E-01 |
| Follicular-VS-Normal |
3.201800E-04 |
| Other-VS-Normal |
2.346800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.017620E-02 |
| Normal-vs-N1 |
6.276800E-01 |
| N0-vs-N1 |
1.902410E-01 |
|
|
